Free Trial

Investors Buy Large Volume of Call Options on Amprius Technologies (NYSE:AMPX)

Amprius Technologies logo with Industrials background

Amprius Technologies, Inc. (NYSE:AMPX - Get Free Report) was the target of some unusual options trading activity on Tuesday. Stock traders bought 2,466 call options on the stock. This represents an increase of 941% compared to the average volume of 237 call options.

Wall Street Analyst Weigh In

A number of equities analysts have recently commented on the stock. Northland Securities cut their target price on shares of Amprius Technologies from $10.00 to $4.00 and set an "outperform" rating on the stock in a research note on Tuesday, August 13th. HC Wainwright reaffirmed a "buy" rating and set a $10.00 price target on shares of Amprius Technologies in a report on Monday, August 12th. Roth Mkm lowered their price target on shares of Amprius Technologies from $10.00 to $6.00 and set a "buy" rating for the company in a report on Friday, August 9th. Northland Capmk raised shares of Amprius Technologies to a "strong-buy" rating in a report on Wednesday, October 2nd. Finally, Oppenheimer decreased their price objective on shares of Amprius Technologies from $15.00 to $14.00 and set an "outperform" rating for the company in a report on Friday, August 9th. One investment analyst has rated the stock with a hold rating, six have issued a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat.com, Amprius Technologies currently has a consensus rating of "Buy" and an average price target of $8.17.

Get Our Latest Research Report on AMPX

Insider Activity

In related news, CEO Kang Sun sold 33,333 shares of the firm's stock in a transaction that occurred on Wednesday, August 21st. The shares were sold at an average price of $1.04, for a total transaction of $34,666.32. Following the sale, the chief executive officer now owns 1,350,753 shares in the company, valued at approximately $1,404,783.12. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other Amprius Technologies news, Director Justin E. Mirro sold 135,000 shares of the stock in a transaction that occurred on Tuesday, September 3rd. The shares were sold at an average price of $1.00, for a total transaction of $135,000.00. Following the transaction, the director now owns 1,510,000 shares of the company's stock, valued at $1,510,000. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CEO Kang Sun sold 33,333 shares of the stock in a transaction that occurred on Wednesday, August 21st. The stock was sold at an average price of $1.04, for a total transaction of $34,666.32. Following the transaction, the chief executive officer now directly owns 1,350,753 shares in the company, valued at approximately $1,404,783.12. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 469,683 shares of company stock worth $425,318 over the last ninety days. 12.80% of the stock is currently owned by insiders.

Institutional Trading of Amprius Technologies

Several hedge funds have recently bought and sold shares of AMPX. AQR Capital Management LLC bought a new stake in Amprius Technologies in the 2nd quarter valued at about $99,000. XTX Topco Ltd bought a new stake in Amprius Technologies in the 2nd quarter valued at about $72,000. Finally, B. Riley Wealth Advisors Inc. raised its position in shares of Amprius Technologies by 84.4% during the 2nd quarter. B. Riley Wealth Advisors Inc. now owns 22,500 shares of the company's stock worth $29,000 after buying an additional 10,300 shares in the last quarter. 5.04% of the stock is currently owned by institutional investors.

Amprius Technologies Stock Performance

Shares of NYSE AMPX traded up $0.05 during midday trading on Tuesday, hitting $1.59. The company's stock had a trading volume of 3,740,095 shares, compared to its average volume of 838,271. Amprius Technologies has a 1-year low of $0.61 and a 1-year high of $6.02. The firm's fifty day moving average price is $1.06 and its 200-day moving average price is $1.32. The firm has a market cap of $171.67 million, a P/E ratio of -3.72 and a beta of 2.71.

Amprius Technologies (NYSE:AMPX - Get Free Report) last posted its quarterly earnings results on Thursday, August 8th. The company reported ($0.13) EPS for the quarter, missing the consensus estimate of ($0.11) by ($0.02). Amprius Technologies had a negative net margin of 327.05% and a negative return on equity of 64.85%. The business had revenue of $3.35 million during the quarter, compared to analyst estimates of $2.45 million. During the same period last year, the firm posted ($0.11) earnings per share. As a group, research analysts predict that Amprius Technologies will post -0.5 earnings per share for the current fiscal year.

About Amprius Technologies

(Get Free Report)

Amprius Technologies, Inc produces and sells ultra-high energy density lithium-ion batteries for mobility applications. The company offers silicon nanowire anode batteries. Its batteries are primarily used for existing and emerging aviation applications, including unmanned aerial systems, such as drones and high-altitude pseudo satellites.

Further Reading

→ Next opportunity for crypto millions (From Crypto 101 Media) (Ad)

Should you invest $1,000 in Amprius Technologies right now?

Before you consider Amprius Technologies, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Amprius Technologies wasn't on the list.

While Amprius Technologies currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Post-Election Chaos or Opportunity? Prepare Your Investments
Strong Markets Meet Rising Volatility—Are Your Investments Safe?
Analysts Bullish on AI-Powered Healthcare: Intuitive Surgical’s 30% Upside

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines